Gregg Czerwieniec
Overview
Explore the profile of Gregg Czerwieniec including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
455
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Caval T, Xu G, Baniasad M, Chu C, Rice R, Hundal I, et al.
Anal Chem
. 2024 Mar;
96(13):5086-5094.
PMID: 38513651
Glycosylation is a key modulator of the functional state of proteins. Recent developments in large-scale analysis of intact glycopeptides have enabled the identification of numerous glycan structures that are relevant...
2.
Chu C, Caval T, Alisson-Silva F, Tankasala A, Guerrier C, Czerwieniec G, et al.
Life Sci Alliance
. 2024 Jan;
7(3).
PMID: 38176728
Monoclonal antibodies targeting the immune checkpoint PD-1 have provided significant clinical benefit across a number of solid tumors, with differences in efficacy and toxicity profiles possibly related to their intrinsic...
3.
Chai I, Kornyeyev D, Hsieh E, Magombedze G, Stapleton L, Hung M, et al.
Sci Rep
. 2022 Dec;
12(1):21286.
PMID: 36494467
The programmed death 1 (PD-1)/programmed death ligand 1 (PD-L1) checkpoint blockade is central to Immuno-Oncology based therapies, and alternatives to antibody blockers of this interaction are an active area of...
4.
Gilmore S, Tam D, Cheung T, Snyder C, Farand J, Dick R, et al.
PLoS One
. 2022 Dec;
17(12):e0271145.
PMID: 36477212
Chronic hepatitis B (CHB) is a global health care challenge and a major cause of liver disease. To find new therapeutic avenues with a potential to functionally cure chronic Hepatitis...
5.
Evans W, Scottoline B, Imam F, Hellerstein M, Garton K, Czerwieniec G, et al.
Pediatr Res
. 2020 Sep;
89(6):1508-1514.
PMID: 32919390
Background: The rate of accrual of muscle mass in neonates has not been assessed. We describe the D-creatine (DCr) dilution method, a noninvasive assessment of muscle mass in neonates. Methods:...
6.
Liclican A, Serafini L, Xing W, Czerwieniec G, Steiner B, Wang T, et al.
Biochim Biophys Acta Gen Subj
. 2020 Jan;
1864(4):129531.
PMID: 31953125
Background: Bruton's tyrosine kinase (BTK) is a key component of the B-cell receptor (BCR) pathway and a clinically validated target for small molecule inhibitors such as ibrutinib in the treatment...
7.
Loomba R, Decaris M, Li K, Shankaran M, Mohammed H, Matthews M, et al.
Clin Infect Dis
. 2018 Dec;
69(3):542-545.
PMID: 30590481
In a pilot study, heavy water labeling was used to determine hepatitis B surface antigen (HBsAg) turnover rates in chronic hepatitis B (CHB) patients. The mean (standard deviation) half-life of...
8.
Shankaran M, Czerwieniec G, Fessler C, Wong P, Killion S, Turner S, et al.
J Cachexia Sarcopenia Muscle
. 2018 Apr;
9(3):540-546.
PMID: 29663711
Background: Muscle mass can be measured directly in vivo by isotope dilution, using Creatine-(methyl-d ) monohydrate (D -Cr) by mouth followed by measurement of the steady-state enrichment of D -creatinine...
9.
Halford J, Shen S, Itamura K, Levine J, Chong A, Czerwieniec G, et al.
J Cereb Blood Flow Metab
. 2017 Aug;
37(10):3278-3299.
PMID: 28816095
Traumatic brain injury (TBI) is an expanding public health epidemic with pathophysiology that is difficult to diagnose and thus treat. TBI biomarkers should assess patients across severities and reveal pathophysiology,...
10.
Levine J, Kwon E, Paez P, Yan W, Czerwieniec G, Loo J, et al.
Glia
. 2015 Dec;
64(5):668-94.
PMID: 26683444
Molecular markers associated with CNS injury are of diagnostic interest. Mechanical trauma generates cellular deformation associated with membrane permeability with unknown molecular consequences. We used an in vitro model of...